ID   LCK_RAT                 Reviewed;         509 AA.
AC   Q01621; B1H265;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   24-MAR-2009, sequence version 3.
DT   02-OCT-2024, entry version 183.
DE   RecName: Full=Proto-oncogene tyrosine-protein kinase LCK;
DE            EC=2.7.10.2;
DE   AltName: Full=Lymphocyte cell-specific protein-tyrosine kinase;
DE   AltName: Full=p56-LCK;
GN   Name=Lck;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Thymus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-18.
RC   STRAIN=Fischer;
RX   PubMed=8423992;
RA   Shin S., Steffen D.L.;
RT   "Frequent activation of the lck gene by promoter insertion and aberrant
RT   splicing in murine leukemia virus-induced rat lymphomas.";
RL   Oncogene 8:141-149(1993).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-192 AND TYR-505, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Non-receptor tyrosine-protein kinase that plays an essential
CC       role in the selection and maturation of developing T-cells in the
CC       thymus and in the function of mature T-cells. Plays a key role in T-
CC       cell antigen receptor (TCR)-linked signal transduction pathways.
CC       Constitutively associated with the cytoplasmic portions of the CD4 and
CC       CD8 surface receptors. Association of the TCR with a peptide antigen-
CC       bound MHC complex facilitates the interaction of CD4 and CD8 with MHC
CC       class II and class I molecules, respectively, thereby recruiting the
CC       associated LCK protein to the vicinity of the TCR/CD3 complex. LCK then
CC       phosphorylates tyrosine residues within the immunoreceptor tyrosine-
CC       based activation motifs (ITAM) of the cytoplasmic tails of the TCR-
CC       gamma chains and CD3 subunits, initiating the TCR/CD3 signaling
CC       pathway. Once stimulated, the TCR recruits the tyrosine kinase ZAP70,
CC       that becomes phosphorylated and activated by LCK. Following this, a
CC       large number of signaling molecules are recruited, ultimately leading
CC       to lymphokine production. LCK also contributes to signaling by other
CC       receptor molecules. Associates directly with the cytoplasmic tail of
CC       CD2, which leads to hyperphosphorylation and activation of LCK. Also
CC       plays a role in the IL2 receptor-linked signaling pathway that controls
CC       the T-cell proliferative response. Binding of IL2 to its receptor
CC       results in increased activity of LCK. Is expressed at all stages of
CC       thymocyte development and is required for the regulation of maturation
CC       events that are governed by both pre-TCR and mature alpha beta TCR.
CC       Phosphorylates other substrates including RUNX3, PTK2B/PYK2, the
CC       microtubule-associated protein MAPT, RHOH or TYROBP (By similarity).
CC       Interacts with UNC119; this interaction plays a crucial role in
CC       activation of LCK (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
CC         [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.2;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU10028};
CC   -!- ACTIVITY REGULATION: The relative activities of the inhibitory
CC       tyrosine-protein kinase CSK and the activating tyrosine-protein
CC       phosphatase PTPRC/CD45 determine the level of LCK activity. These
CC       interactions allow rapid and efficient activation of LCK in response to
CC       TCR stimulation (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Binds to the cytoplasmic domain of cell surface receptors,
CC       such as AXL, CD2, CD4, CD5, CD8, CD44, CD45 and CD122. Also binds to
CC       effector molecules, such as PI4K, VAV1, RASA1, FYB1 and to other
CC       protein kinases including CDK1, RAF1, ZAP70 and SYK. Binds to
CC       phosphatidylinositol 3'-kinase (PI3K) from T-lymphocytes through its
CC       SH3 domain and to the tyrosine phosphorylated form of KHDRBS1/p70
CC       through its SH2 domain. Interacts with SQSTM1. Interacts with
CC       phosphorylated LIME1. Interacts with CBLB and PTPRH. Interacts with
CC       RUNX3. Forms a signaling complex with EPHA1, PTK2B and PI3-KINASE; upon
CC       activation by EFNA1 which may regulate T-lymphocytes migration.
CC       Associates with ZAP70 and RHOH; these interactions allow LCK-mediated
CC       RHOH and CD3 subunit phosphorylations in presence of a functional
CC       ZAP70. Interacts with CEACAM1 (via cytoplasmic domain); mediates
CC       CEACAM1 phosphorylation resulting in PTPN6 recruitment that
CC       dephosphorylates TCR stimulation-induced CD247 and ZAP70. Interacts
CC       with FYB2. Interacts with CD160. Interacts with CD48.
CC       {ECO:0000250|UniProtKB:P06239}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P06239};
CC       Lipid-anchor {ECO:0000250|UniProtKB:P06239}; Cytoplasmic side
CC       {ECO:0000250|UniProtKB:P06239}. Cytoplasm, cytosol
CC       {ECO:0000250|UniProtKB:P06239}. Note=Present in lipid rafts in an
CC       inactive form. {ECO:0000250|UniProtKB:P06239}.
CC   -!- PTM: Autophosphorylated on Tyr-394, increasing enzymatic activity, this
CC       site is dephosphorylated by PTN22. Phosphorylated on Tyr-505 by CSK,
CC       decreasing activity. Dephosphorylated by PTPRC/CD45. Dephosphorylation
CC       at Tyr-394 by PTPN2 negatively regulates T-cells differentiation (By
CC       similarity). Dephosphorylation at Tyr-394 by DUSP22 negatively
CC       regulates T-cell receptor signaling (By similarity). {ECO:0000250,
CC       ECO:0000250|UniProtKB:P06239}.
CC   -!- PTM: Myristoylation is required prior to palmitoylation. {ECO:0000250}.
CC   -!- PTM: Palmitoylation regulates association with the plasma membrane and
CC       could be mediated by ZDHHC2. {ECO:0000250|UniProtKB:P06239}.
CC   -!- PTM: 'Lys-63'-linked ubiquitinated at Lys-99 and Lys-276 by UBR2; this
CC       modification is required for autophosphorylation at Tyr-394.
CC       {ECO:0000250|UniProtKB:P06239}.
CC   -!- DISEASE: Note=Proviral insertion upstream of the Lck gene causes
CC       overexpression, leading to the development of thymic lymphoma.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. SRC subfamily. {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CH473968; EDL80546.1; -; Genomic_DNA.
DR   EMBL; BC160881; AAI60881.1; -; mRNA.
DR   EMBL; Z15029; CAA78748.1; -; Genomic_DNA.
DR   PIR; I58370; S24780.
DR   RefSeq; NP_001094179.1; NM_001100709.1.
DR   RefSeq; XP_006238995.1; XM_006238933.3.
DR   RefSeq; XP_008762362.1; XM_008764140.2.
DR   AlphaFoldDB; Q01621; -.
DR   BMRB; Q01621; -.
DR   SMR; Q01621; -.
DR   IntAct; Q01621; 3.
DR   STRING; 10116.ENSRNOP00000012936; -.
DR   iPTMnet; Q01621; -.
DR   PhosphoSitePlus; Q01621; -.
DR   jPOST; Q01621; -.
DR   PaxDb; 10116-ENSRNOP00000012936; -.
DR   GeneID; 313050; -.
DR   KEGG; rno:313050; -.
DR   AGR; RGD:2994; -.
DR   CTD; 3932; -.
DR   RGD; 2994; Lck.
DR   eggNOG; KOG0197; Eukaryota.
DR   HOGENOM; CLU_000288_7_2_1; -.
DR   InParanoid; Q01621; -.
DR   OrthoDB; 1614410at2759; -.
DR   PhylomeDB; Q01621; -.
DR   TreeFam; TF351634; -.
DR   Reactome; R-RNO-114604; GPVI-mediated activation cascade.
DR   Reactome; R-RNO-1257604; PIP3 activates AKT signaling.
DR   Reactome; R-RNO-1433557; Signaling by SCF-KIT.
DR   Reactome; R-RNO-1433559; Regulation of KIT signaling.
DR   Reactome; R-RNO-202424; Downstream TCR signaling.
DR   Reactome; R-RNO-202427; Phosphorylation of CD3 and TCR zeta chains.
DR   Reactome; R-RNO-202430; Translocation of ZAP-70 to Immunological synapse.
DR   Reactome; R-RNO-202433; Generation of second messenger molecules.
DR   Reactome; R-RNO-210990; PECAM1 interactions.
DR   Reactome; R-RNO-2424491; DAP12 signaling.
DR   Reactome; R-RNO-389356; CD28 co-stimulation.
DR   Reactome; R-RNO-389357; CD28 dependent PI3K/Akt signaling.
DR   Reactome; R-RNO-389359; CD28 dependent Vav1 pathway.
DR   Reactome; R-RNO-389513; CTLA4 inhibitory signaling.
DR   Reactome; R-RNO-389948; PD-1 signaling.
DR   Reactome; R-RNO-6811558; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling.
DR   Reactome; R-RNO-9013407; RHOH GTPase cycle.
DR   Reactome; R-RNO-9020558; Interleukin-2 signaling.
DR   PRO; PR:Q01621; -.
DR   Proteomes; UP000002494; Unplaced.
DR   Proteomes; UP000234681; Chromosome 5.
DR   GO; GO:0005911; C:cell-cell junction; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; IEA:UniProtKB-SubCell.
DR   GO; GO:0030139; C:endocytic vesicle; IDA:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0001772; C:immunological synapse; ISO:RGD.
DR   GO; GO:0045121; C:membrane raft; ISO:RGD.
DR   GO; GO:0000242; C:pericentriolar material; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0099091; C:postsynaptic specialization, intracellular component; IDA:SynGO.
DR   GO; GO:0003823; F:antigen binding; IPI:RGD.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0051117; F:ATPase binding; ISO:RGD.
DR   GO; GO:0042609; F:CD4 receptor binding; ISO:RGD.
DR   GO; GO:0042610; F:CD8 receptor binding; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; ISO:RGD.
DR   GO; GO:0043548; F:phosphatidylinositol 3-kinase binding; ISO:RGD.
DR   GO; GO:0016004; F:phospholipase activator activity; ISO:RGD.
DR   GO; GO:0043274; F:phospholipase binding; ISO:RGD.
DR   GO; GO:0001784; F:phosphotyrosine residue binding; ISO:RGD.
DR   GO; GO:1990405; F:protein antigen binding; ISO:RGD.
DR   GO; GO:0019901; F:protein kinase binding; ISO:RGD.
DR   GO; GO:0019903; F:protein phosphatase binding; ISO:RGD.
DR   GO; GO:0004722; F:protein serine/threonine phosphatase activity; ISO:RGD.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; IDA:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:RGD.
DR   GO; GO:0042169; F:SH2 domain binding; ISO:RGD.
DR   GO; GO:0005102; F:signaling receptor binding; IBA:GO_Central.
DR   GO; GO:0042608; F:T cell receptor binding; ISO:RGD.
DR   GO; GO:0050853; P:B cell receptor signaling pathway; ISO:RGD.
DR   GO; GO:0007169; P:cell surface receptor protein tyrosine kinase signaling pathway; IBA:GO_Central.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; ISO:RGD.
DR   GO; GO:0038094; P:Fc-gamma receptor signaling pathway; ISO:RGD.
DR   GO; GO:0042492; P:gamma-delta T cell differentiation; ISO:RGD.
DR   GO; GO:0045087; P:innate immune response; IBA:GO_Central.
DR   GO; GO:0035556; P:intracellular signal transduction; ISO:RGD.
DR   GO; GO:0006882; P:intracellular zinc ion homeostasis; ISO:RGD.
DR   GO; GO:0045588; P:positive regulation of gamma-delta T cell differentiation; ISO:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:0034116; P:positive regulation of heterotypic cell-cell adhesion; ISO:RGD.
DR   GO; GO:2001244; P:positive regulation of intrinsic apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:1903039; P:positive regulation of leukocyte cell-cell adhesion; ISO:RGD.
DR   GO; GO:0050870; P:positive regulation of T cell activation; ISO:RGD.
DR   GO; GO:0042531; P:positive regulation of tyrosine phosphorylation of STAT protein; ISO:RGD.
DR   GO; GO:0070474; P:positive regulation of uterine smooth muscle contraction; IMP:RGD.
DR   GO; GO:0045589; P:regulation of regulatory T cell differentiation; ISO:RGD.
DR   GO; GO:0050856; P:regulation of T cell receptor signaling pathway; ISO:RGD.
DR   GO; GO:0051209; P:release of sequestered calcium ion into cytosol; ISO:RGD.
DR   GO; GO:1904044; P:response to aldosterone; IEP:RGD.
DR   GO; GO:0042542; P:response to hydrogen peroxide; IDA:RGD.
DR   GO; GO:0009612; P:response to mechanical stimulus; IMP:RGD.
DR   GO; GO:0010038; P:response to metal ion; IDA:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; ISO:RGD.
DR   GO; GO:0010043; P:response to zinc ion; IEP:RGD.
DR   GO; GO:0030217; P:T cell differentiation; ISO:RGD.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; ISO:RGD.
DR   CDD; cd05067; PTKc_Lck_Blk; 1.
DR   CDD; cd10362; SH2_Src_Lck; 1.
DR   CDD; cd12005; SH3_Lck; 1.
DR   Gene3D; 3.30.505.10; SH2 domain; 1.
DR   Gene3D; 2.30.30.40; SH3 Domains; 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR035850; Lck_SH2.
DR   InterPro; IPR035749; Lck_SH3.
DR   InterPro; IPR050198; Non-receptor_tyrosine_kinases.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR036860; SH2_dom_sf.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   PANTHER; PTHR24418; TYROSINE-PROTEIN KINASE; 1.
DR   PANTHER; PTHR24418:SF39; TYROSINE-PROTEIN KINASE LCK; 1.
DR   Pfam; PF07714; PK_Tyr_Ser-Thr; 1.
DR   Pfam; PF00017; SH2; 1.
DR   Pfam; PF00018; SH3_1; 1.
DR   PRINTS; PR00401; SH2DOMAIN.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00252; SH2; 1.
DR   SMART; SM00326; SH3; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   SUPFAM; SSF55550; SH2 domain; 1.
DR   SUPFAM; SSF50044; SH3-domain; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS50001; SH2; 1.
DR   PROSITE; PS50002; SH3; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Cell membrane; Cytoplasm; Isopeptide bond; Kinase;
KW   Lipoprotein; Membrane; Myristate; Nucleotide-binding; Palmitate;
KW   Phosphoprotein; Proto-oncogene; Reference proteome; SH3 domain;
KW   Transferase; Tyrosine-protein kinase; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT   CHAIN           2..509
FT                   /note="Proto-oncogene tyrosine-protein kinase LCK"
FT                   /id="PRO_0000088126"
FT   DOMAIN          61..121
FT                   /note="SH3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   DOMAIN          127..224
FT                   /note="SH2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00191"
FT   DOMAIN          245..498
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          2..72
FT                   /note="Interactions with CD4 and CD8"
FT                   /evidence="ECO:0000250"
FT   REGION          154..242
FT                   /note="Interaction with PTPRH"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        364
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10028"
FT   BINDING         251..259
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         273
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         102
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P06239"
FT   MOD_RES         159
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P06239"
FT   MOD_RES         162
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P06239"
FT   MOD_RES         192
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         194
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P06239"
FT   MOD_RES         394
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P06239"
FT   MOD_RES         505
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   LIPID           2
FT                   /note="N-myristoyl glycine"
FT                   /evidence="ECO:0000250"
FT   LIPID           3
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250"
FT   LIPID           5
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250"
FT   CROSSLNK        99
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:P06239"
FT   CROSSLNK        276
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:P06239"
SQ   SEQUENCE   509 AA;  57890 MW;  B23F3F4BEF3D6654 CRC64;
     MGCVCSSNPE DDWMENIDVC ENCHYPIVPL DSKSTLPIRT GSEVRDPLVT YEGSLPPASP
     LQDNLVIALH SYEPSHDGDL GFEKGEQLRI LEQSGEWWKA QSLTTGQEGF IPFNFVAKAN
     SLEPEPWFFK NLSRKDAERQ LLAPGNTHGS FLIRESESTA GSFSLSVRDF DQNQGEVVKH
     YKIRNLDNGG FYISPRITFP GLHDLVRHYT NASDGLCTKL SRPCQTQKPQ KPWWEDEWEV
     PRETLKLVER LGAGQFGEVW MGYYNGHTKV AVKSLKQGSM SPDAFLAEAN LMKQLQHPRL
     VRLYAVVTQE PIYIITEYME NGSLVDFLKT PSGIKLNVNK LLDMAAQIAE GMAFIEEQNY
     IHRDLRAANI LVSDTLSCKI ADFGLARLIE DNEYTAREGA KFPIKWTAPE AINYGTFTIK
     SDVWSFGILL TEIVTHGRIP YPGMTNPEVI QNLEKGYRMV RPDNCPEELY HLMMLCWKER
     PEDRPTFDYL RSVLDDFFTA TEGQYQPQP
//
